Cardiovascular risk reduction in chronic myeloid leukemia patients treated with the tyrosine kinase inhibitors by N. Lopina, I. Dmytrenko, D. Lopin, D. Hamov, I. Dyagil

Get full text

Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia by Rafael Martínez-Fonseca, Cruz Vargas-De-León, Ramón Reyes-Carreto, Flaviano Godínez-Jaimes

Subjects: “…chronic myeloid leukemia…”
Get full text

Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation by Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud, Bjørn Tore Gjertsen

“…Chronic myeloid leukemia (CML) is a myeloproliferative disorder in which neoplastic cells exhibit the Philadelphia chromosome and the related oncoprotein BCR-ABL1. …”
Get full text

To study demographic profile, risk stratification, and response to treatment in chronic myeloid leukemia patients by Manish Chandey, Rajandeep Kaur, Rajeev Gupta, Gurinder Mohan

Subjects: “…chronic myeloid leukemia…”
Get full text

Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia by N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov

Subjects: “…chronic myeloid leukemia…”
Get full text

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients by Stefania Stella, Silvia Rita Vitale, Fabio Stagno, Michele Massimino, Adriana Puma, Cristina Tomarchio, Maria Stella Pennisi, Elena Tirrò, Chiara Romano, Francesco Di Raimondo, Emma Cacciola, Rossella Cacciola, Livia Manzella

Subjects: “…chronic myeloid leukemia…”
Get full text

Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review by Dan Ran Castillo, Daniel Park, Akhil Mehta, Simmer Kaur, Anthony Nguyen, Mojtaba Akhtari

Subjects: Get full text

MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML) by Ibrahim C. Haznedaroglu

“…The aim of oral tyrosine kinase inhibitor (TKI) treatment in chronic myeloid leukemia (CML) is to get ideal hematological, cytogenetic, molecular responses at the critical time-points. …”
Get full text

Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donors. by Mackinnon, S, Hows, J, Goldman, J, Arthur, C, Hughes, T, Apperley, J, Jones, L, Batchelor, JR, Brookes, P, Catovsky, D

“…We treated 17 patients with chronic myeloid leukemia (CML) by bone marrow transplantation using marrow from human leukocyte antigen (HLA)-matched unrelated donors. …”

A man with concomitant polycythaemia vera and chronic myeloid leukemia: the dynamics of the two disorders by Bee, P.C., Gan, G.G., Nadarajan, V.S., Latiff, N.A., Menaka, N.

“…We report a 60-year-old man who initially presented with phenotype of polycythemia vera (PV), which evolved into chronic myeloid leukemia and back to PV once treatment with imatinib was commenced. …”

T315I – a gatekeeper point mutation and its impact on the prognosis of chronic myeloid leukemia by Kaleem Bushra, Shahab Sadaf, Shamsi Tahir Sultan

Get full text

Molecular diagnosis of Iraqi chronic myeloid leukemia patients using quantitative real-time PCR by Adeeb Abbas, Majeed A. Sabbah, Abdul-salam Hatam, Luma A. Yasser, Baan Abdul-Latif

Get full text

Unraveling the unexpected: A rare case of filariasis in chronic myeloid leukemia with a review of the literature by Nikhil Kumar

“…Here, we report a case of chronic myeloid leukemia in the chronic phase associated with Wuchereria bancrofti. …”
Get full text

A practical guide to managing cardiopulmonary toxicities of tyrosine kinase inhibitors in chronic myeloid leukemia by Rasha Kaddoura, Wafer A. Dabdoob, Khalid Ahmed, Mohamed A. Yassin

Subjects: “…chronic myeloid leukemia…”
Get full text

P657: PATHOGENESIS OF TYROSINE KINASE INHIBITOR–ASSOCIATED VASCULAR TOXICITY IN CHRONIC MYELOID LEUKEMIA by Ayala Gover Proaktor, Galit Granot, Oren Pasvolsky, Pia Raanani, Avi Leader

Get full text

Nilotinib-Induced Dystonia and Cognitive Deficits in a Neurologically Normal Patient with Chronic Myeloid Leukemia by Justine Chan, Paarth Shah, Guillermo Moguel-Cobos

“…Nilotinib is a tyrosine kinase inhibitor used to treat patients with chronic myeloid leukemia (CML). This agent is also being studied in neurodegenerative disorders including Parkinson disease. …”
Get full text

Imatinib- and Nilotinib-Induced Lichenoid Eruption in Chronic Myeloid Leukemia: A Rare Case Report by Meenakshi Sachdeva, Jayanti Singh, Surabhi Dayal, Aanchal Gupta

Subjects: “…chronic myeloid leukemia…”
Get full text

DNA Damage Response (DDR) Is Associated With Treatment-free Remission in Chronic Myeloid Leukemia Patients by Federica Malighetti, Giulia Arosio, Chiara Manfroni, Mario Mauri, Matteo Villa, Beatrice Manghisi, Elena Inzoli, Giovanni Rindone, Giovanni P. M. Zambrotta, Ivan Civettini, Veronica Guglielmana, Daniele Ramazzotti, Giovanni Giudici, Silvia Bombelli, Roberto Perego, Rocco Piazza, Luca Mologni, Carlo Gambacorti-Passerini

Get full text

Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report by Yousef Mohammed Ali Hailan, Deena Mudawi, Mohamed A. Yassin

Subjects: Get full text

Concomitant chronic myeloid leukemia and monoclonal B cell lymphocytosis - a very rare condition by Sara Duarte, Sónia Campelo Pereira, Élio Rodrigues, Amélia Pereira

Get full text